EGFR and glioblastoma: The current WHO 2021 classification defines glioblastoma as IDH-wt, and describes it as involving frequent alterations associated with mutations in the telomerase reverse transcriptase (TERT) promoter, amplifications of the epidermal growth factor receptor (EGFR), and single-copy loss of chromosome 10 and gain in chromosome 7 [5].